About this trial
Investigation of the feasibility of monitoring processed transcutaneous electroencephalography (EEG), a method of interpreting brain activity, and near-infrared spectroscopy (NIRS), a method of determining levels of tissue oxygenation (StO2) in the brain, for patients with acute respiratory distress syndrome (ARDS) in the ICU.
Eligibility criteria
Qualifiers
Adult patient admitted to the ICU
ARDS confirmed according to the Berlin Definition
Invasive mechanical ventilation
Deep sedation and/or neuromuscular blockade required for ARDS treatment at the discretion of the treating medical team
Disqualifiers
More than 24 hours elapsed since ICU admission
Death is deemed imminent and inevitable during the next 24 hours
Known allergy to a textile component of the device
Consent declined from patient or authorized third party
Trial design
Treatments tested in this trial
- Masimo O3 NIRS cerebral oximetry and SedLine processed EEG